300639 凯普生物
已收盘 03-20 15:00:00
资讯
新帖
简况
股市必读：凯普生物(300639)股东户数4.12万户，较上期减少4.12%
证券之星 · 03-18
股市必读：凯普生物(300639)股东户数4.12万户，较上期减少4.12%
凯普生物：公司与您提及的泓博医药暂无相关合作
证券之星 · 03-17
凯普生物：公司与您提及的泓博医药暂无相关合作
凯普生物：截至2026年3月10日，公司股东总户数为41,221户
证券之星 · 03-17
凯普生物：截至2026年3月10日，公司股东总户数为41,221户
凯普生物（300639）披露全资子公司取得医疗器械注册证书，3月4日股价上涨0.32%
证券之星 · 03-04
凯普生物（300639）披露全资子公司取得医疗器械注册证书，3月4日股价上涨0.32%
凯普生物(300639.SZ)子公司取得一项医疗器械注册证
智通财经 · 03-04
凯普生物(300639.SZ)子公司取得一项医疗器械注册证
凯普生物股东拟减持不超过3%股份，减持期为3月6日至6月5日
美股速递 · 02-04
凯普生物股东拟减持不超过3%股份，减持期为3月6日至6月5日
凯普生物最新公告：股东云南众合之拟减持不超3%股份
证券之星 · 02-04
凯普生物最新公告：股东云南众合之拟减持不超3%股份
凯普生物（300639）披露全资子公司完成工商设立登记公告，1月30日股价下跌3.78%
证券之星 · 01-30
凯普生物（300639）披露全资子公司完成工商设立登记公告，1月30日股价下跌3.78%
凯普生物(300639.SZ)发预亏，预计2025年归母净亏损1.2亿元至1.95亿元
智通财经 · 01-27
凯普生物(300639.SZ)发预亏，预计2025年归母净亏损1.2亿元至1.95亿元
凯普生物最新公告：公司近期经营情况正常不存在应披露而未披露的重大事项
证券之星 · 01-27
凯普生物最新公告：公司近期经营情况正常不存在应披露而未披露的重大事项
异动快报：凯普生物（300639）1月27日14点19分触及涨停板
证券之星 · 01-27
异动快报：凯普生物（300639）1月27日14点19分触及涨停板
10分钟股价涨超10%！多家上市公司称已具备尼帕病毒检测能力
21世纪经济报道 · 01-27
10分钟股价涨超10%！多家上市公司称已具备尼帕病毒检测能力
异动快报：凯普生物（300639）1月26日13点0分触及涨停板
证券之星 · 01-26
异动快报：凯普生物（300639）1月26日13点0分触及涨停板
凯普生物：截至2026年1月9日股东总户数为27,001户
证券之星 · 01-20
凯普生物：截至2026年1月9日股东总户数为27,001户
凯普生物：1月13日高管王建瑜增持股份合计190万股
证券之星 · 01-14
凯普生物：1月13日高管王建瑜增持股份合计190万股
1月13日凯普生物现1笔折价24.63%的大宗交易 合计成交872.1万元
证券之星 · 01-13
1月13日凯普生物现1笔折价24.63%的大宗交易 合计成交872.1万元
凯普生物(300639.SZ)获实际控制人之一王建瑜增持400万股 后续拟继续增持
智通财经 · 01-12
凯普生物(300639.SZ)获实际控制人之一王建瑜增持400万股 后续拟继续增持
股市必读：1月9日凯普生物现1笔折价20.25%的大宗交易 合计成交1812万元
证券之星 · 01-12
股市必读：1月9日凯普生物现1笔折价20.25%的大宗交易 合计成交1812万元
凯普生物：1月7日高管谢龙旭减持股份合计9.39万股
证券之星 · 01-07
凯普生物：1月7日高管谢龙旭减持股份合计9.39万股
凯普生物最新公告：全资子公司潮州凯普生物化学有限公司生产许可证变更
证券之星 · 2025-12-17
凯普生物最新公告：全资子公司潮州凯普生物化学有限公司生产许可证变更
加载更多
公司概况
公司名称：
广东凯普生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2017-04-12
主营业务：
广东凯普生物科技股份有限公司的主营业务是分子诊断产品、医学检验服务、医疗大健康服务。公司的主要产品是自产产品、检验服务、外购产品、医疗服务。公司HPV检测产品连续九次参与WHOHPV网络监测评估，许多关键的单项标准都名列国际前茅。
发行价格：
18.39
{"stockData":{"symbol":"300639","market":"SZ","secType":"STK","nameCN":"凯普生物","latestPrice":6.37,"timestamp":1773990225000,"preClose":6.6,"halted":0,"volume":24444032,"delay":0,"changeRate":-0.0348,"floatShares":635000000,"shares":647000000,"eps":-0.8054,"marketStatus":"已收盘","change":-0.23,"latestTime":"03-20 15:00:00","open":6.61,"high":6.68,"low":6.36,"amount":158000000,"amplitude":0.0485,"askPrice":6.38,"askSize":6426,"bidPrice":6.37,"bidSize":76,"shortable":0,"etf":0,"ttmEps":-0.8054,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"adjPreClose":6.6,"symbolType":"stock","openAndCloseTimeList":[[1773970200000,1773977400000],[1773982800000,1773990000000]],"highLimit":7.26,"lowLimit":5.94,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":646500674,"isCdr":false,"pbRate":1.11,"roa":"--","roe":"--","epsLYR":-1.02,"committee":-0.543729,"marketValue":4118000000,"turnoverRate":0.0385,"status":1,"floatMarketCap":4046000000},"requestUrl":"/m/hq/s/300639","defaultTab":"news","newsList":[{"id":"2620472245","title":"股市必读：凯普生物(300639)股东户数4.12万户，较上期减少4.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620472245","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620472245?lang=zh_cn&edition=full","pubTime":"2026-03-18 02:19","pubTimestamp":1773771550,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，凯普生物报收于6.61元，下跌0.9%，换手率2.05%，成交量13.04万手，成交额8727.17万元。来自股本股东变化：截至2026年3月10日，公司股东户数环比减少4.12%，户均持股上升至1.57万股，呈现筹码集中趋势。股本股东变化股东户数变动近日凯普生物披露，截至2026年3月10日公司股东户数为4.12万户，较2月27日减少1771.0户，减幅为4.12%。户均持股数量由上期的1.5万股增加至1.57万股，户均持股市值为10.57万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800001358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300639","BK0132","BK0042","BK0046"],"gpt_icon":0},{"id":"2620942738","title":"凯普生物：公司与您提及的泓博医药暂无相关合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2620942738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620942738?lang=zh_cn&edition=full","pubTime":"2026-03-17 20:52","pubTimestamp":1773751934,"startTime":"0","endTime":"0","summary":"证券之星消息，凯普生物(300639)03月16日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，注意到公司在布局AI制药相关方面，也注意到公司在和泓博医药有AI制药AI大模型相关的合作，泓博医药可以说是国内AI制药第一股，现在市值这么低潜力这么巨大，公司为什么不直接控股或者收购呢凯普生物回复：您好，感谢您的关注。公司与您提及的泓博医药暂无相关合作，关于公司的对外投资情况请留意公司的相关公告及定期报告。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700039681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300639","BK0216","301230","BK0042","BK0239","BK0046"],"gpt_icon":0},{"id":"2620412287","title":"凯普生物：截至2026年3月10日，公司股东总户数为41,221户","url":"https://stock-news.laohu8.com/highlight/detail?id=2620412287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620412287?lang=zh_cn&edition=full","pubTime":"2026-03-17 11:36","pubTimestamp":1773718608,"startTime":"0","endTime":"0","summary":"证券之星消息，凯普生物(300639)03月16日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至3月10日公司的股东人数是多少？谢谢凯普生物回复：您好，感谢您的关注，截至2026年3月10日，公司股东总户数为41,221户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700017065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0042","BK0046","300639"],"gpt_icon":0},{"id":"2616556461","title":"凯普生物（300639）披露全资子公司取得医疗器械注册证书，3月4日股价上涨0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616556461","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616556461?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:17","pubTimestamp":1772633836,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘，凯普生物报收于6.29元，较前一交易日上涨0.32%，最新总市值为40.66亿元。该股当日开盘6.23元，最高6.36元，最低6.21元，成交额达1.16亿元，换手率为2.91%。近日，广东凯普生物科技股份有限公司全资子公司广州凯普医药科技有限公司联合广东省妇幼保健院研发的染色体多重STR基因分型试剂盒取得国家药品监督管理局颁发的医疗器械注册证，注册证编号为国械注准20263400439，有效期至2031年3月2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400040173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK1583","09996","BK0132","BK0239","BK1100","BK1574","BK1222","159883","BK0046","BK0042","09997"],"gpt_icon":0},{"id":"2616553517","title":"凯普生物(300639.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2616553517","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616553517?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:40","pubTimestamp":1772617228,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯普生物(300639.SZ)公告，公司全资子公司广州凯普医药科技有限公司(简称“凯普医药”)联合广东省妇幼保健院共同攻关研发的染色体(13/18/21/X/Y)多重STR基因分型试剂盒(荧光PCR毛细管电泳法)取得国家药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409989.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0046","BK1583","BK0042","BK1100","159883","09996","BK1574","300639","09997","BK1222","BK0132"],"gpt_icon":0},{"id":"1196549126","title":"凯普生物股东拟减持不超过3%股份，减持期为3月6日至6月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=1196549126","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196549126?lang=zh_cn&edition=full","pubTime":"2026-02-04 18:25","pubTimestamp":1770200701,"startTime":"0","endTime":"0","summary":"凯普生物（股票代码：300639）近日披露，公司一名主要股东计划在未来三个月内减持公司股份。根据公告，该股东拟通过集中竞价或大宗交易方式，减持不超过公司总股本3%的股份。\n此次减持窗口期设定为2024年3月6日至6月5日。公司表示，此次减持计划系股东自身资金需求安排，不会导致公司控制权发生变更，也不会对公司的治理结构和持续经营产生重大影响。市场人士将密切关注该减持计划对二级市场股价可能带来的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","BK0046","BK0042","BK0239","300639"],"gpt_icon":0},{"id":"2608357202","title":"凯普生物最新公告：股东云南众合之拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608357202","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608357202?lang=zh_cn&edition=full","pubTime":"2026-02-04 18:21","pubTimestamp":1770200464,"startTime":"0","endTime":"0","summary":"凯普生物(300639.SZ)公告称，持股5%以上股东云南众合之企业管理有限公司计划自公告披露之日起15个交易日后的3个月内（即2026年3月6日至2026年6月5日），以集中竞价交易或大宗交易方式减持公司股份不超过1939.50万股，占公司总股本的3%；减持原因为自身资金需求；股份来源为公司首次公开发行前持有的股份及资本公积金转增股本部分。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400031941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","BK0042","BK0046","300639"],"gpt_icon":0},{"id":"2607041396","title":"凯普生物（300639）披露全资子公司完成工商设立登记公告，1月30日股价下跌3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607041396","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607041396?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:24","pubTimestamp":1769783066,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，凯普生物报收于7.64元，较前一交易日下跌3.78%，最新总市值为49.39亿元。该股当日开盘8.01元，最高8.8元，最低7.58元，成交额达9.43亿元，换手率为18.3%。近日，广东凯普生物科技股份有限公司披露《关于全资子公司完成工商设立登记的公告》。公告显示，公司已完成全资子公司潮州唐风宋韵文化有限公司的工商设立登记，并取得由潮州市湘桥区市场监督管理局核发的营业执照。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0046","BK0239","BK0042","300639"],"gpt_icon":0},{"id":"2606786325","title":"凯普生物(300639.SZ)发预亏，预计2025年归母净亏损1.2亿元至1.95亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606786325","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606786325?lang=zh_cn&edition=full","pubTime":"2026-01-27 19:40","pubTimestamp":1769514026,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯普生物(300639.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净亏损1.2亿元至1.95亿元;扣除非经常性损益后的净亏损1.43亿元至2.18亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398119.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"凯普生物(300639.SZ)发预亏，预计2025年归母净亏损1.2亿元至1.95亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300639","BK0132","BK0046","BK0239","BK0042"],"gpt_icon":0},{"id":"2606830077","title":"凯普生物最新公告：公司近期经营情况正常不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2606830077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606830077?lang=zh_cn&edition=full","pubTime":"2026-01-27 19:10","pubTimestamp":1769512253,"startTime":"0","endTime":"0","summary":"凯普生物(300639.SZ)公告称，公司于2026年1月26日、2026年1月27日连续两个交易日收盘价格涨幅偏离值累计超过30%，属于股票交易异常波动情形。经核查，公司前期披露的信息不存在需要更正、补充之处，未发现近期公共传媒报道了与公司相关且市场关注度较高的未公开重大信息，近期经营情况及内外部经营环境未发生重大变化。公司、控股股东和实际控制人不存在关于公司的应披露而未披露的重大事项，或处于筹划阶段的重大事项。公司预计2025年度亏损1.20亿元到1.95亿元。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700034786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","BK0046","300639","BK0132"],"gpt_icon":0},{"id":"2606208887","title":"异动快报：凯普生物（300639）1月27日14点19分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2606208887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606208887?lang=zh_cn&edition=full","pubTime":"2026-01-27 14:21","pubTimestamp":1769494865,"startTime":"0","endTime":"0","summary":"证券之星1月27日盘中消息，14点19分凯普生物（300639）触及涨停板。其所属行业医疗器械目前下跌。领涨股为凯普生物。该股为尼帕病毒，基因测序，猴痘概念概念热股，当日尼帕病毒概念上涨3.52%。1月26日的资金流向数据方面，主力资金净流入1.28亿元，占总成交额29.5%，游资资金净流出6276.37万元，占总成交额14.48%，散户资金净流出6514.12万元，占总成交额15.03%。近5日资金流向一览见下表：凯普生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700019636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0042","BK0132","BK0239","BK0046"],"gpt_icon":0},{"id":"2606245208","title":"10分钟股价涨超10%！多家上市公司称已具备尼帕病毒检测能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2606245208","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606245208?lang=zh_cn&edition=full","pubTime":"2026-01-27 14:12","pubTimestamp":1769494320,"startTime":"0","endTime":"0","summary":"1月27日，博晖创新盘中突然拉升翻红，10分钟涨超10%，截至13：30，涨8.34%，报7.79元/股。消息面上，博晖创新当日发文称，公司已自主研发了尼帕病毒核酸检测试剂盒。 2024年年报显示，博晖创新HPV检测产品、微量元素检测产品、质谱相关检测产品营收居前，分别占总营收的12.89%、4.71%、10.71%，尼帕病毒检测产品未见上榜。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2026-01-27/doc-inhitntx9835883.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-01-27/doc-inhitntx9835883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MNDmain","BK0046","BK0251","BK0239","BK0028","300639","BK0132","300318","603658","BK0042","BK0048"],"gpt_icon":0},{"id":"2606229521","title":"异动快报：凯普生物（300639）1月26日13点0分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2606229521","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606229521?lang=zh_cn&edition=full","pubTime":"2026-01-26 13:05","pubTimestamp":1769403938,"startTime":"0","endTime":"0","summary":"证券之星1月26日盘中消息，13点0分凯普生物触及涨停板。其所属行业医疗器械目前下跌。领涨股为之江生物。该股为猴痘概念，肝炎概念，辅助生殖概念热股，当日猴痘概念概念上涨1.98%，肝炎概念概念上涨1.16%，辅助生殖概念上涨1.02%。1月23日的资金流向数据方面，主力资金净流入321.41万元，占总成交额5.31%，游资资金净流入59.38万元，占总成交额0.98%，散户资金净流出380.79万元，占总成交额6.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600013620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0132","BK0042","BK0046","BK0239"],"gpt_icon":0},{"id":"2604192163","title":"凯普生物：截至2026年1月9日股东总户数为27,001户","url":"https://stock-news.laohu8.com/highlight/detail?id=2604192163","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604192163?lang=zh_cn&edition=full","pubTime":"2026-01-20 11:34","pubTimestamp":1768880066,"startTime":"0","endTime":"0","summary":"证券之星消息，凯普生物(300639)01月19日在投资者关系平台上答复投资者关心的问题。投资者提问：你好 请问截止至2026年1月9日股东人数是多少 谢谢凯普生物回复：您好，感谢您的关注，截至2026年1月9日，公司股东总户数为27,001户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000014299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","300639","BK0042","BK0132"],"gpt_icon":0},{"id":"2603616451","title":"凯普生物：1月13日高管王建瑜增持股份合计190万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603616451","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603616451?lang=zh_cn&edition=full","pubTime":"2026-01-14 21:02","pubTimestamp":1768395739,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月14日市场公开信息、上市公司公告及交易所披露数据整理，凯普生物最新董监高及相关人员股份变动情况：2026年1月13日公司董事,高管王建瑜共增持公司股份190.0万股，占公司总股本为0.2939%。凯普生物近半年内的董监高及核心技术人员增减持详情如下：凯普生物的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出375.26万，融资余额减少；融券净流入3.0万，融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400039599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0042","300639","BK0132"],"gpt_icon":0},{"id":"2603050239","title":"1月13日凯普生物现1笔折价24.63%的大宗交易 合计成交872.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603050239","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603050239?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:33","pubTimestamp":1768296793,"startTime":"0","endTime":"0","summary":"证券之星消息，1月13日凯普生物发生大宗交易，交易数据如下：大宗交易成交价格4.59元，相对当日收盘价折价24.63%，成交190万股，成交金额872.1万元，买方营业部为国投证券股份有限公司潮州分公司，卖方营业部为红塔证券股份有限公司广州珠江东路证券营业部。近三个月该股共发生2笔大宗交易，合计成交5.9万手，折价成交2笔。截至2026年1月13日收盘，凯普生物报收于6.09元，上涨6.1%，换手率6.74%，成交量42.78万手，成交额2.63亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300029377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0132","300639","BK0046","BK0239"],"gpt_icon":0},{"id":"2602592175","title":"凯普生物(300639.SZ)获实际控制人之一王建瑜增持400万股 后续拟继续增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2602592175","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602592175?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:19","pubTimestamp":1768205973,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯普生物(300639.SZ)发布公告，公司近日收到实际控制人之一、董事、总经理王建瑜女士的《告知函》，获悉王建瑜女士于2026年1月9日以其自有资金通过大宗交易方式增持公司股份400万股，增持均价为4.53元/股，合计增持金额1,812万元(不含交易费用)。同时，王建瑜女士计划自2026年1月13日起6个月内通过大宗交易方式继续增持公司股份，本次拟增持股份的金额不低于1200万元人民币(含交易费用，且不含本次披露的首次增持金额)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"凯普生物(300639.SZ)获实际控制人之一王建瑜增持400万股 后续拟继续增持","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0046","BK0042","300639","BK0132"],"gpt_icon":0},{"id":"2602626557","title":"股市必读：1月9日凯普生物现1笔折价20.25%的大宗交易 合计成交1812万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602626557","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602626557?lang=zh_cn&edition=full","pubTime":"2026-01-12 02:26","pubTimestamp":1768155970,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，凯普生物报收于5.68元，上涨0.35%，换手率1.43%，成交量9.07万手，成交额5137.69万元。来自交易信息汇总：当日发生一笔折价20.25%的大宗交易，合计成交1812万元，值得关注后续走势影响。交易信息汇总资金流向1月9日主力资金净流出745.92万元；游资资金净流入254.03万元；散户资金净流入491.88万元。大宗交易1月9日凯普生物发生1笔折价20.25%的大宗交易，合计成交1812万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200000974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","300639","BK0042","BK0132"],"gpt_icon":0},{"id":"2601876230","title":"凯普生物：1月7日高管谢龙旭减持股份合计9.39万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601876230","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601876230?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:32","pubTimestamp":1767778365,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月7日市场公开信息、上市公司公告及交易所披露数据整理，凯普生物最新董监高及相关人员股份变动情况：2026年1月7日公司职工代表董事谢龙旭共减持公司股份9.39万股，占公司总股本为0.0145%。凯普生物近半年内的董监高及核心技术人员增减持详情如下：凯普生物的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出210.17万，融资余额减少；融券净流入4100.0，融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700026989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0239","BK0132","BK0046","BK0042"],"gpt_icon":0},{"id":"2592995668","title":"凯普生物最新公告：全资子公司潮州凯普生物化学有限公司生产许可证变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2592995668","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592995668?lang=zh_cn&edition=full","pubTime":"2025-12-17 17:43","pubTimestamp":1765964626,"startTime":"0","endTime":"0","summary":"凯普生物(300639.SZ)公告称，全资子公司潮州凯普生物化学有限公司近日收到广东省药品监督管理局颁发的《医疗器械生产许可证》，涉及生产范围的变更。变更后的生产许可证显示，潮州凯普生物化学有限公司的生产地址包括广东省潮州市经济开发试验区北片高新区D5-3-3-4以及潮州市湘桥区创北路1号凯普综合楼第四层、第五层、第六层B区，生产范围新增Ⅱ类18妇产科、辅助生殖和避孕器械，有效期至2029年1月8日。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700027802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0042","BK0132","BK0239","BK0046"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774226249335,"stockEarnings":[{"period":"1week","weight":-0.0392},{"period":"1month","weight":-0.0632},{"period":"3month","weight":0.1355},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.046},{"period":"ytd","weight":0.184}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东凯普生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41221人(较上一季度减少4.12%)","perCapita":"15408股","listingDate":"2017-04-12","address":"广东省潮州市湘桥区经济开发试验区北片高新区D5-3-3-4小区","registeredCapital":"64650万元","survey":" 广东凯普生物科技股份有限公司的主营业务是分子诊断产品、医学检验服务、医疗大健康服务。公司的主要产品是自产产品、检验服务、外购产品、医疗服务。公司HPV检测产品连续九次参与WHOHPV网络监测评估，许多关键的单项标准都名列国际前茅。","listedPrice":18.39},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯普生物(300639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯普生物(300639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯普生物,300639,凯普生物股票,凯普生物股票老虎,凯普生物股票老虎国际,凯普生物行情,凯普生物股票行情,凯普生物股价,凯普生物股市,凯普生物股票价格,凯普生物股票交易,凯普生物股票购买,凯普生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯普生物(300639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯普生物(300639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}